EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The cannabinoid type 2 receptor agonist, HU308, reduces cytokine secretion in LPS-stimulated RAW 264.7 macrophages

Stefan Hall, Kayle Dickson, Juan Zhou, Zhenyu Cheng, Christian Lehmann

Journal of Cellular Biotechnology · 2026

DOI: 10.1177/23523689251384468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biotechnology, 2026. Verfasst von Stefan Hall und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anesthesia Research Fund.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inflammatory mediators produced by macrophages play a key role in the immune response to sepsis. Agonism of the cannabinoid receptor two represents a promising anti-inflammatory strategy that can modulate macrophage activation in this context. In this article, we highlight the use of the synthetic cannabinoid HU-308 as an anti-inflammatory therapeutic agent in an in vitro model of macrophage inflammation.

Methods

To this end, RAW 264.7 murine macrophages were stimulated with lipopolysaccharide and their production of inflammatory mediators was evaluated using enzyme-linked immunosorbant assays. Further, we evaluated macrophage viability with HU-308 treatment and confirmed the expression of the cannabinoid receptor 2.

Results

We identified a dose-related reduction in the secretion of IL-6, TNF, and CXCL8.

Conclusion

HU-308 is a promising candidate for reducing inflammation secondary to macrophage activation, indicating the value of additional research on this topic.

Förderung

  • Anesthesia Research Fund

Zitieren

APA

Hall, S., Dickson, K., Zhou, J., Cheng, Z., & Lehmann, C. (2026). The cannabinoid type 2 receptor agonist, HU308, reduces cytokine secretion in LPS-stimulated RAW 264.7 macrophages. Journal of Cellular Biotechnology. https://doi.org/10.1177/23523689251384468

Vancouver

Hall S, Dickson K, Zhou J, Cheng Z, Lehmann C. The cannabinoid type 2 receptor agonist, HU308, reduces cytokine secretion in LPS-stimulated RAW 264.7 macrophages. Journal of Cellular Biotechnology. 2026. doi:10.1177/23523689251384468

BibTeX
@article{Hall2026,
  author = {Hall, Stefan and Dickson, Kayle and Zhou, Juan and Cheng, Zhenyu and Lehmann, Christian},
  title = {The cannabinoid type 2 receptor agonist, HU308, reduces cytokine secretion in LPS-stimulated RAW 264.7 macrophages},
  journal = {Journal of Cellular Biotechnology},
  year = {2026},
  doi = {10.1177/23523689251384468}
}
Kostenlos starten →